Episode 621: Aducanumab is not effective for mild cognitive impairment or mild Alzheimer's dementia and has major safety issues

POEM of the Week Podcast - Podcast tekijän mukaan Mark Ebell and Michael Wilkes

kokeile Podimo ilmaiseksi 30! päivän ajan

kokeile Podimo ilmaiseksi 30! päivän ajan

universumia joka on täynnä satoja podcasteja ja äänikirjoja, klikkaa tätä kokeillaksesi

 Sponsored

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' Aducanumab is not effective for mild cognitive impairment or mild Alzheimer's dementia and has major safety issues '

Visit the podcast's native language site